tiprankstipranks
Trending News
More News >
Inmune Bio Inc (INMB)
NASDAQ:INMB
US Market

Inmune Bio (INMB) Income Statement

Compare
698 Followers

Inmune Bio Income Statement

Last quarter (Q3 2024), Inmune Bio's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Inmune Bio's net income was $-12.09M. See Inmune Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 14.00K$ 155.00K$ 374.00K$ 181.00K$ 10.92K
Gross Profit
$ 14.00K$ 155.00K$ 374.00K$ 181.00K$ 10.92K
Operating Expenses
$ 42.65M$ 29.90M$ 26.32M$ 29.33M$ 12.24M
Depreciation and Amortization
$ 0.00$ 0.00$ 25.95M$ 29.15M$ 12.23M
EBITDA
$ 0.00$ -29.74M$ 0.00$ 0.00$ 0.00
Operating Income
$ -42.63M$ -29.74M$ -25.95M$ -29.15M$ -12.23M
Other Income/Expenses
$ 84.72M$ -267.00K$ -1.35M$ -1.19M$ 129.00K
Pretax Income
$ 42.08M$ -30.01M$ -27.30M$ -30.34M$ -12.10M
Net Income
$ 42.08M$ -30.01M$ -28.65M$ -30.34M$ -12.10M
Per Share Metrics
Basic EPS
$ 2.08$ -1.67$ -1.60$ -1.88$ -1.01
Diluted EPS
$ 2.08$ -1.67$ -1.60$ -1.88$ -1.01
Weighted Average Shares Outstanding
20.19M 17.98M 17.93M 16.13M 11.99M
Weighted Average Shares Outstanding (Diluted)
20.19M 17.98M 17.93M 16.13M 11.99M
Currency in USD

Inmune Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis